JOINTAS(SZ:002909)2022-04-28 16:00Financial Performance - The company's revenue for Q1 2022 was CNY 335,455,694.72, representing a 13.57% increase compared to CNY 295,379,056.07 in the same period last year[3]. - Net profit attributable to shareholders decreased by 83.67% to CNY 554,881.00 from CNY 3,397,447.50 year-on-year[3]. - The company experienced a 51.47% decline in operating profit, which was CNY 2,004,536.13 compared to CNY 4,130,237.91 in the previous year[10]. - The net profit for Q1 2022 was CNY 545,803.18, a decrease from CNY 3,184,834.83 in the previous period[25]. - The total comprehensive income for the first quarter of 2022 was CNY 554,881,000, a decrease from CNY 3,397,447,500 in the previous year[26]. - Basic and diluted earnings per share for the first quarter were CNY 0.0015, compared to CNY 0.0085 in the same period last year[26]. Cash Flow and Liquidity - The net cash flow from operating activities was negative CNY 61,720,844.79, a decline of 42.57% compared to negative CNY 43,290,098.41 in the previous year[11]. - Cash inflow from operating activities totaled CNY 242,676,314.39, up from CNY 195,814,836.60 year-over-year[29]. - The company reported cash outflow from operating activities of CNY 304,397,159.18, an increase from CNY 239,104,935.01 in the previous year[29]. - The ending balance of cash and cash equivalents was CNY 223,632,051.72, down from CNY 404,202,997.21 at the end of the previous year[30]. - As of March 31, 2022, cash and cash equivalents decreased to RMB 243.61 million from RMB 411.17 million at the beginning of the year[20]. Assets and Liabilities - The company's total assets increased by 0.57% to CNY 1,899,878,849.03 from CNY 1,889,106,452.17 at the end of the previous year[3]. - The total liabilities for Q1 2022 were CNY 1,064,151,875.94, compared to CNY 1,044,386,863.13 in the previous period[22]. - The total liabilities decreased by 34.82% in other payables, amounting to CNY 22,973,989.21 compared to CNY 35,249,600.26 in the previous year[10]. - The company's equity attributable to shareholders was CNY 834,768,602.72, down from CNY 842,569,990.91 in the previous period[23]. Research and Development - Research and development expenses rose by 45.94% to CNY 13,853,108.34 from CNY 9,492,433.65 in the previous year[10]. - The research and development expenses for Q1 2022 were CNY 13,853,108.34, up from CNY 9,492,433.65 in the previous period, indicating a focus on innovation[24]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 11,149[13]. - The largest shareholder, Guangzhou Antai Chemical Co., Ltd., holds 40.06% of shares, totaling 149,325,614 shares[14]. - The company has repurchased a total of 2,800,609 shares, accounting for 0.751% of the total share capital, with a total expenditure of approximately RMB 19.52 million[15]. Other Financial Metrics - The company's inventory increased by 64.54% to CNY 178,080,962.88 from CNY 108,230,028.39 year-on-year[10]. - The company reported a credit impairment loss of CNY -2,570,741.98 for Q1 2022, compared to CNY -275,372.38 in the previous period, reflecting increased credit risk[25]. - The company's short-term borrowings were CNY 326,757,792.44, slightly down from CNY 328,381,725.30 in the previous period, indicating stable financing[22]. - The company has successfully acquired land use rights for two plots of land in Anhui province[18]. - The company has returned RMB 10 million of idle raised funds to the special account ahead of schedule[16]. - The company plans to continue using up to RMB 16.6 million of idle raised funds for cash management[17].